Management of late intrauterine death using a combination of mifepristone and misoprostol - Experience of two regimens

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 118, Issue 1, 2005, Pages 28-31

  Fairley, Tara E ^a,b   Mackenzie, Maureen ^a   Owen, Philip ^a   Mackenzie, Fiona ^a  

^a Scotland ^*  (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Intrauterine death; Mifepristone; Misoprostol

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS DEATH; GASTROINTESTINAL TOXICITY; HUMAN; LABOR INDUCTION; PREGNANCY; PRIORITY JOURNAL; UTERUS CONTRACTION; UTERUS RUPTURE; VAGINAL DELIVERY;

EID: 10644297008     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.04.001     Document Type: Article

References (16)

1. El-Rafaey H., Rajaseker D., Abdalla M., Calder L., Templeton A. Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. New Engl. J. Med. 332:1995;983-987
2. Bugalho A., Bique C., Machungo F., Faaundes A. Induction of labour with intravaginal misoprostol in intrauterine fetal death. Am. J. Obstet. Gynaecol. 171:1994;538-541
3. Plaut M.M., Schwartz M.I., Lubarsky S.L. Uterine rupture associated with the use of misoprostol in gravid patients with previous Caesarean section. Am. J. Obstet. Gynaecol. 180:1999;1535-1542
4. Wing D.A., Ham D., Paul R.H. A comparison of oral administration of misoprostol with vaginal administration of misoprostol for cervical ripening and labour induction. Am. J. Obstet. Gynaecol. 180(5):1999;1155-1160
5. Adair C.P., Weeks J.W., Barrilleaux S., Edwards M., Burlison K., Lewis D.F. Oral or vaginal misoprostol administration for induction of labour: a randomised double-blind trial. Obstet. Gynaecol. 92(5):1998;810-813
6. Windirm R., Challis D., Johnson J.M., Akoury H., Seaward P. Misoprostol versus intra-amniotic prostaglandin F2 alpha in termination of pregnancy complicated by fetal anomaly. Am. J. Obstet. Gynecol. 178(1S):1998;133
7. Scher J., Moshirpur J., Kerenyi T.D. A comparison between vaginal prostaglandin E sub 2 suppositories and intrauterine extra-amniotic prostaglandin in the management of deaths in utero. Am. J. Obstet. Gynecol. 137:1980;769-772
8. Danielian P., Porter B., Ferri N., Summers J., Templeton A. Misoprostol for induction of labour at term. A more effective agent than dinoprostone vaginal gel. BJOG. 106(8):1999;793-797
9. Bugalho A., Bique C., Machungo F., Bergstrom S. Vaginal misoprostol as an alternative to oxytocin for induction of labour in women with late fetal death. Acta Obstet. Gynecol. Scand. 74(3):1995;194-198
10. Cabrol D., Dubois C., Cronje H., Gonnet J.M. Induction of labour with mifepristone (RU486) in intrauterine fetal death. Am. J. Obstet. Gynecol. 163:1990;540-542
11. Wagaarachi P.T., Ashok P., Narvekar N., Smith N., Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Hum. Reprod. 16:2002;1849-1853
12. Wagaarachi P.T., Ashok P., Narvekar N., Smith N., Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG. 109:2002;443-447
13. Chittachareon A., Herabutya Y., Punyavachira P. A randomised trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet. Gynecol. 101:2003;70-73
14. Bugalho A., Bique C., Machungo F., Bergstrom S. Vaginal misoprostol as an alternative to oxytocin for the induction of labour in women with late fetal death. Acta Obstet. Gynecol. Scand. 74:1995;194-198
15. Zieman M., Fong S.K., Bencwiz N.L. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet. Gynecol. 90:1990;88-92
16. Tang O.S., Schweer H., Seyberth H.W., Lee S.W., Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum. Reprod. 17(2):2002;332-336